Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2022-02-22 4:16 pm Purchase | 13D | AGEX THERAPEUTICS INC AGE | Juvenescence Ltd | 48,871,797 69.5% | 9,380,260 (+23.75%) | View |
2022-02-14 4:40 pm Sale | 13D | AGEX THERAPEUTICS INC AGE | Juvenescence Ltd | 39,491,537 64.8% | -4,756,168 (-10.75%) | View |
2021-12-13 4:16 pm Purchase | 13D | AGEX THERAPEUTICS INC AGE | Juvenescence Ltd | 44,247,705 67.3% | 7,621,441 (+20.81%) | View |
2021-11-18 4:15 pm Unchanged | 13D | AGEX THERAPEUTICS INC AGE | Juvenescence Ltd | 36,626,264 63% | 0 (Unchanged) | View |
2021-11-02 4:15 pm Purchase | 13D | AGEX THERAPEUTICS INC AGE | Juvenescence Ltd | 36,626,264 63% | 3,795,380 (+11.56%) | View |
2021-09-14 4:17 pm Purchase | 13D | AGEX THERAPEUTICS INC AGE | Juvenescence Ltd | 32,830,884 60.4% | 4,071,286 (+14.16%) | View |
2021-05-26 4:15 pm Purchase | 13D | AGEX THERAPEUTICS INC AGE | Juvenescence Ltd | 28,759,598 57.2% | 1,281,204 (+4.66%) | View |
2021-05-11 4:17 pm Purchase | 13D | AGEX THERAPEUTICS INC AGE | Juvenescence Ltd | 27,478,394 56.1% | 3,778,640 (+15.94%) | View |
2021-02-17 4:40 pm Purchase | 13D | AGEX THERAPEUTICS INC AGE | Juvenescence Ltd | 23,699,754 52.7% | 168,727 (+0.72%) | View |
2021-02-09 4:15 pm Sale | 13D | AGEX THERAPEUTICS INC AGE | Juvenescence Ltd | 23,531,027 52.6% | -128,134 (-0.54%) | View |
2021-01-12 4:18 pm Purchase | 13D | AGEX THERAPEUTICS INC AGE | Juvenescence Ltd | 23,659,161 52.7% | 2,419,702 (+11.39%) | View |
2020-11-19 5:24 pm Unchanged | 13D | AGEX THERAPEUTICS INC AGE | Juvenescence Ltd | 21,239,459 50% | 0 (Unchanged) | View |
2020-10-16 4:35 pm Sale | 13G | AGEX THERAPEUTICS INC AGE | IBS CAPITAL LLC | 1,883,746 4.998% | -828,000 (-30.53%) | View |
2020-10-07 4:16 pm Purchase | 13D | AGEX THERAPEUTICS INC AGE | Juvenescence Ltd | 21,239,459 50% | 30,545 (+0.14%) | View |
2020-07-31 4:02 pm Purchase | 13D | AGEX THERAPEUTICS INC AGE | Juvenescence Ltd | 21,208,914 50% | 4,371,097 (+25.96%) | View |
2020-04-06 4:04 pm Purchase | 13D | AGEX THERAPEUTICS INC AGE | Juvenescence Ltd | 16,837,817 44.2% | 268,817 (+1.62%) | View |
2019-08-16 4:01 pm Purchase | 13D | AGEX THERAPEUTICS INC AGE | Juvenescence Ltd | 16,569,000 43.8% | 169,000 (+1.03%) | View |